[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Page 19596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9788]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated January 9, 2009, and published in the Federal 
Register on January 21, 2009 (74 FR 3642), Noramco Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by letter to the Drug 
Enforcement Administration (DEA) to be registered as an importer of 
Thebaine (9333), a basic class of controlled substance listed in 
schedule II.
    The company plans to import analytical reference standards for 
distribution to its customers for research purposes.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Noramco Inc. to import the basic class of controlled 
substance is consistent with the public interest, and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Noramco Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: April 17, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-9788 Filed 4-28-09; 8:45 am]
BILLING CODE 4410-09-P